Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

2670
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, Animal Health, and Others.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.

The Others segment includes all activities that do not qualify as reportable segments under IFRS 8 “Operating Segments”; it also includes the effects of retained commitments in respect of divested businesses.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 113 496 persons.
Sales per Businesses
20132014Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,25082.7%27,72082.1% +1.7%
Vaccines3,71611.3%3,97411.8% +6.49%
Animal Health1,9856%2,0766.1% +4.38%
Other-----
Sales per Regions
20132014Delta
EUR (in Million)%EUR (in Million)%
Other Countries11,44134.7%11,45333.9% +0.1%
United States10,43331.7%11,33933.6% +7.99%
Europe7,93324.1%7,93223.5% -0.01%
France2,5717.8%2,4747.3% -3.92%
North America573.001.7%572.001.7% -0.17%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD592015Chief Executive Officer
Serge Weinberg642009Chairman
Jérôme Contamine582009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD642011President-Global Research & Development
Igor Landau712004Director
Robert Castaigne, PhD692000Independent Director
Jean-René Fourtou762004Independent Director
Claudie Haigneré MD, PhD582008Independent Director
Uwe Bicker PhD, MD702008Independent Director
Gérard van Kemmel, MBA762003Independent Director
Shareholders
NameShares%
L'Oréal SA 118,444,357 9.06%
Norges Bank Investment Management 29,478,279 2.25%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.70%
Dodge & Cox 21,972,552 1.68%
The Vanguard Group, Inc. 19,770,031 1.51%
Plan d'Epargne Entreprise Sanofi Synthelabo 17,075,788 1.31%
Amundi SA (Investment Management) 15,862,089 1.21%
Natixis Asset Management SA 15,592,205 1.19%
BlackRock Fund Advisors 12,284,562 0.94%
Lyxor International Asset Management SAS 11,929,637 0.91%
Holdings
NameShares%Valuation
Regeneron Pharmaceuticals Inc (REGN) 22,859,14422.6%11,716,682,849 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,051,60311.9%1,317,664,637 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%758,004,891 USD
Sanofi India Ltd (SANOFI) 13,909,58760.4%758,004,891 USD
Zentiva SA (ROSCD) 312,341,64974.9%174,224,172 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%66,050,053 USD
Merrimack Pharmaceuticals Inc (MACK) 3,074,7182.79%36,281,672 USD
Immune Design Corp (IMDZ) 917,4294.59%20,027,475 USD
SCYNEXIS Inc (SCYX) 1,677,05712.1%14,489,772 USD
Proteome Sciences plc (PRM) 46,0000.021%15,618 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
ALLERGAN PLC
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Sanofi : Connections
Financière BFSA
Aventis Foundation
Montres CORUM Sàrl
Weinberg Capital Partners SAS
Sanofi-Aventis Europe SAS
Institute of Medicine
Sanofi-Aventis Participations SA
Financières SASA
Piasa Holding
Piasa SA
VL Holding (France)
Sanofi Pasteur Holding SA
The Children's Aid Society, Inc.
The Johns Hopkins University
Sanofi-Aventis U.S. LLC
INSEAD
Fondation C.Génial
Alliance Automotive Group SAS
École Normale Supérieure
Bordeaux University Foundation
Universcience.fr
Financière Piasa
Pres héSam
Academie des Sports
Académie des Sciences et Technologies
Fondation de France
Mayo Clinic
L'Oréal Corporate Foundation
Lasker Foundation
Fondations René Lacoste
Research!America
Académie des Technologies
King Abdullah University of Science & Technology
Academie de l'air et de l'espace
Académie Nationale de Médecine
Philipps University of Marburg
National Academy of Engineering
Ruprecht-Karls-Universität Heidelberg
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Euronext, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem